Bíonn fáilte agus fiche roimh chuireadh gan iarraidh.
There
is great welcome in an unrequested invitation.
Major Canine Cancer
Breakthrough
June 5, 2009 by Jennifer White
The (US) Food & Drug Administration approves new
cancer drug for dogs: Whilst conducting medical trials, the drug called
Palladia or toceranib phosphate, has been found to reduce cutaneous
mast-cell tumours better than a placebo alternative.
These mast-cell tumours are responsible for one-in-five skin tumours
found in dogs, which are often found as lumps on the skin but can be
spread to other places. These are the second most common form of the 1.2
million cases of cancer reported each year in dogs.
Vets have been treating dogs for cancer for years but have mainly used
chemotherapy drugs developed for humans and have never rigorously tested
on dogs.
The Food & Drug Administration are out to prove Palladia’s effectiveness
in canines and at the end of trials presented to the FDA 60% of dogs
treated with the drug had their skin tumours shrink, disappear or stop
growing.
These results were according to a news release from Pfizer Animal
Health, the makers of Palladia.
The newspaper reports that the vice president of Pfizer Animal Health,
George Fennell said that Palladia won’t be available in vets until 2010.
He said that until then any dog owner’s should discuss treatments with
their vet who may refer their dog to a specialist for treatment with
Palladia.
Source: Dog Magazine
